About Adolore Biotherapeutics
Adolore Biotherapeutics is a private company based in Delray Beach, Florida, incorporated in 2021 in Delaware. It has reported $1,330,000 raised in three offerings on Form D since January 2022. Its chief executive is Roelof Rongen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2025 | Sep 29, 2025 | $25,000of $1.0M target | 1 | $25,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 15, 2023 | Jan 25, 2024 | $1,055,000target not set | 22 | $47,955 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jan 6, 2022 | Jan 13, 2022 | $250,000of $2.5M target | 3 | $83,333 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $1,330,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Adolore Biotherapeutics's Form D filed Sep 29, 2025.
PB
Paul Barone
Executive officer, director and promoter
MR
Mark Rogers
Director
RR
Roelof Rongen
CEO and director
RL
Roy Levitt
Executive officer, director and promoter
Earlier filings also listed Lou Altieri (cfo and director, last listed Jan 2022).